Penile cancer accounts for less than 1% of male cancers in the United States. Localized disease, particularly T1 tumors are potentially curable with local therapy. We present the racial differences in survival outcomes for T1, penile cancer from the SEER database.
From 2004 to 2016 all men with T1, N0, M0 penile cancer in the SEER-18 database were included. Kaplan-Meier analysis and multivariable Cox-Regression analysis were conducted to investigate prognostic variables for cancer specific survival (CSS).
A total of 4,406 men were identified with penile cancer; 1,941 men had T1 disease. The Kaplan-Meier (KM) analysis showed those with primary site surgery had better 5-year CSS compared to those without primary site surgery (P <.0001) and a significant difference in CSS based on race (P= 0.0078). On multivariable analysis, Hispanic individuals had worse CSS (HR 1.92; P = 0.0057) compared to the White men. Black men were also found to have a poor CSS however this was not statistically significant (HR 1.53, P = 0.118). Men with penile cancer who had either penectomy (HR 0.45; P = 0.006) or penile preservation surgery (HR 0.25; P< 0.001) had improved CSS.
Racial disparities in CSS exist among men with in early-stage penile cancer. KM analysis showed significant differences in CSS by race and in those receiving primary site surgery. On multivariable analysis, the CSS is worse in Hispanic compared to White men. There is a trend towards worse CSS in Black men however this was not statistically significant.
Urologic oncology. 2023 Jun 19 [Epub ahead of print]
Nellowe C Candelario, Elizabeth Molina, Maria T Bourlon, Simon P Kim, Elizabeth R Kessler, Philippe E Spiess, Thomas W Flaig
Division of Medical Oncology, University of Colorado Cancer Center Anschutz Medical Campus, Aurora, CO., Hemato-Oncology Deparment, Urologic Oncology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Division of Urology, University of Colorado Cancer Center Anschutz Medical Campus, Aurora, CO., Department of GU Oncology and Tumor Biology, Moffitt Cancer Center, Tampa, FL., Division of Medical Oncology, University of Colorado Cancer Center Anschutz Medical Campus, Aurora, CO. Electronic address: .